Authors: STIGBRAND T ANDRES C BELLANGER L OMARY MB BODENMULLER H BONFRER H BRUNDELL J EINARSSON R ERLANDSSON A JOHANSSON A LECA JF LEVI M MEIER T NAP M NUSTAD K SEGUIN P SJODIN A SUNDSTROM B VANDALEN A WIEBELHAUS E WIKLUND B ARLESTIG L HILGERS J

Citation: T. Stigbrand et al., EPITOPE SPECIFICITY OF 30 MONOCLONAL-ANTIBODIES AGAINST CYTOKERATIN ANTIGENS - THE ISOBM TD5-1 WORKSHOP, Tumor biology, 19(2), 1998, pp. 132-152

Authors: STIGBRAND T ULLEN A SANDSTROM P RATHSMAN S NORRLUND RR ARLESTIG L AHLSTROM KR HIETALA SO

Citation: T. Stigbrand et al., ENDOGENOUS ANTITUMOR ANTIBODY-RESPONSES IN NUDE-MICE, Cancer, 80(12), 1997, pp. 2404-2410

Authors: STIGBRAND T ULLEN A SANDSTROM P MIRZAIEJONIANI H SUNDSTROM B NILSSON B ARLESTIG L NORRLUND RR AHLSTROM KR HIETALA SO

Citation: T. Stigbrand et al., 20 YEARS WITH MONOCLONAL-ANTIBODIES - STATE-OF-THE-ART - WHERE DO WE GO, Acta oncologica, 35(3), 1996, pp. 259-265

Authors: ULLEN A AHLSTROM KR HIETALA SO NILSSON B ARLESTIG L STIGBRAND T

Citation: A. Ullen et al., SECONDARY ANTIBODIES AS TOOLS TO IMPROVE TUMOR TO NON TUMOR RATIO AT RADIOIMMUNOLOCALIZATION AND RADIOIMMUNOTHERAPY, Acta oncologica, 35(3), 1996, pp. 281-285

Authors: ULLEN A SANDSTROM P AHLSTROM KR SUNDSTROM B NILSSON B ARLESTIG L STIGBRAND T

Citation: A. Ullen et al., USE OF ANTICYTOKERATIN MONOCLONAL ANTIIDIOTYPIC ANTIBODIES TO IMPROVETUMOR NONTUMOR RATIO IN EXPERIMENTAL RADIOIMMUNOLOCALIZATION/, Cancer research, 55(23), 1995, pp. 5868-5873